Skip to main navigation Skip to search Skip to main content

Multi-center, Phase II Study to Assess the Safety and Preliminary Efficacy of Multiple Doses of INH-A21, a Donor-Selected Human Staphylococcal Immune Globulin, in Very Low Birth Weight Infants

Project: Research

Project Details

StatusFinished
Effective start/end date02/19/03 → 01/14/05

Funding

  • Inhibitex Inc: $2,000.00